期刊文献+

阿司匹林肠溶片对妊高征高危人群的干预作用 被引量:4

下载PDF
导出
摘要 目的:探讨小剂量阿司匹林肠溶片对妊高征高危患者病情进展及凝血功能的干预作用。方法:将86例妊高征高危患者按照随机数字表法分成观察组(46例)和对照组(40例),观察组口服小剂量阿司匹林肠溶片(50mg/d)治疗,对照组口服相同剂量安慰剂处理,两组患者均用药至预产期前两周。对比分析两组患者妊高征的发病率以及凝血功能各项指标的变化。结果:观察组妊高征的发病率为17.39%;对照组为37.50%,差异有统计学意义(P<0.05)。对照组APTT、PT以及TT各项指标均低于观察组,差异均有统计学意义(P<0.05)。对照组FIB的含量高于观察组,差异有统计学意义(P<0.05)。结论:小剂量阿司匹林肠溶片可有效减少妊高征高危人群转变为妊高征,并能够改善其血液的凝血功能。
作者 牛蕊
出处 《北方药学》 2015年第12期17-18,共2页 Journal of North Pharmacy
  • 相关文献

参考文献7

  • 1Kaneva FM, Frolov AL, Akhmetova VG, et al. The character- istics of hemostasis condition in women with non-carrylng of preg- nancy[J]. Klin Lab Diagn, 2012, Aug(4 ) : 37-41.
  • 2Huissoud C, Carrabin N, Benehaib M, et al. Coagulation assess- mentby rotation thrombelastometry in normal pregnancy[J]. Thromb Haemost, 2009, 101 (4) : 755-761.
  • 3McLean KC, Bernstein IM, Brummel-Ziedins KE. Tissue fac- tor-dependent thrombin generation across pregnancy[J]. Am J Ob- stet Gynecol, 2012,207(2 ) : 1-6.
  • 4廖晓芳.妊高症妇女凝血功能及D-二聚体检测的临床意义[J].中外医学研究,2013,11(20):71-72. 被引量:15
  • 5朱义芳.凝血功能与妊娠期高血压疾病的相关性分析[J].现代诊断与治疗,2014,25(21):4989-4990. 被引量:2
  • 6Carbillon L, Uzan S. Early treatment with low-doseaspirin is ef- fective for the prevention of preeclampsia andrelated complications in high-risk patients selected by the analysis of their historic risk factors [J]. Blood, 2005,105(2) : 902-903.
  • 7Stavrakis S, Stoner J A, Azar M, et al. Low-dose aspirin for primary prevention of cardiovascular events in patients with dia- betes: a meta-analysis [J]. Am J Med Sci, 2011,341( 1 ):1-9.

二级参考文献11

  • 1Kaneva F M,Frolov A L,Akhmetova V G. The characteristics of hemostasis condition in women with non-carrying of pregnancy[J].{H}Klinicheskaia Laboratornaia Diagnostika,2012.37-41.
  • 2Della Rocca G,Dogareschi T,Cecconet T. Coagulation assessment in normal pregnancy:thrombelastography with citrated non activated samples[J].{H}Minerva Anestesiologica,2012,(12):1357-1364.
  • 3Huissoud C,Carrabin N,Benchaib M. Coagulation assessment by rotation thrombelastometry in normal pregnancy[J].{H}Thrombosis and Haemostasis,2009,(04):755-761.
  • 4McLean K C,Bernstein I M,Brummel-Ziedins K E. Tissue factor-dependent thrombin generation across pregnancy[J].{H}AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY,2012,(02):1-6.
  • 5Karlsson O,Sporrong T,Hillarp A. Prospective longitudinal study of thromboelastography and standard hemostatic laboratory tests in healthy women during normal pregnancy[J].{H}Anesthesia and Analgesia,2012,(04):890-898.
  • 6Lockshin M D,Kim M,Laskin C A. Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant,but not anticardiolipin antibody,in patients with antiphospholipid antibodies[J].{H}ARTHRITIS AND RHEUMATISM,2012,(07):2311-2318.
  • 7James A. Practice bulletin no.123:thromboembolism in pregnancy[J].{H}OBSTETRICS AND GYNECOLOGY,2011,(03):718-729.
  • 8Robb A O,Mills N L,Din J N. Acute endothelial tissue plasminogen activator release in pregnancy[J].{H}Journal of Thrombosis and Haemostasis,2009,(01):138-142.
  • 9张春荣,张翠波.妊娠期高血压疾病患者凝血功能指标的检测及其临床意义[J].中国妇幼保健,2011,26(3):472-473. 被引量:22
  • 10谭小羽.正常妊娠、妊娠期糖尿病及妊娠期高血压的凝血功能检测及意义[J].四川医学,2013,34(3):438-439. 被引量:23

共引文献15

同被引文献24

引证文献4

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部